Epistaxis resident survival guide: Difference between revisions
Amir Bagheri (talk | contribs) (→Causes) |
Amir Bagheri (talk | contribs) |
||
Line 130: | Line 130: | ||
{{familytree | J01 | | J02 | |!| | | |`|-|-|-|^|-|-|-| J03 | | |J01= [[Bleeding]] controlled|J02= [[Bleeding]] resume|J03=[[Rist factor]] assessment}} | {{familytree | J01 | | J02 | |!| | | |`|-|-|-|^|-|-|-| J03 | | |J01= [[Bleeding]] controlled|J02= [[Bleeding]] resume|J03=[[Rist factor]] assessment}} | ||
{{familytree | |!| | | |!| | |!| | | | | | | | | | | | |!| | | | | |}} | {{familytree | |!| | | |!| | |!| | | | | | | | | | | | |!| | | | | |}} | ||
{{familytree | |!| | | |`|-|-| K02 | | | | | | | | | | K03 | |K01=K01|K02=Suspected [[Bleeding]] site [[HHT]]** or | {{familytree | |!| | | |`|-|-| K02 | | | | | | | | | | K03 | |K01=K01|K02=Suspected [[Bleeding]] site [[HHT]]** or on [[anticoagulant]]s?| K03=Patient education and [[prevention]] }} | ||
{{Familytree | |!| | | | | |,|-|-|^|-|-|.| | | | | | | |!| }} | {{Familytree | |!| | | | | |,|-|-|^|-|-|.| | | | | | | |!| }} | ||
{{Familytree | |!| | | | | E01 | | | | E02 | | | | | | E03 | | | | | |E01=NO→[[Non absorbable]] or [[Absorbable packing]](Preferred in children)| E02=Yes→[[Absorbable packing]]| E03=Outcome Assesment}} | {{Familytree | |!| | | | | E01 | | | | E02 | | | | | | E03 | | | | | |E01=NO→[[Non absorbable]] or [[Absorbable packing]](Preferred in children)| E02=Yes→[[Absorbable packing]]| E03=Outcome Assesment}} | ||
Line 143: | Line 143: | ||
{{Familytree | | | | |!| | | | | | I03 | | | |!| | |I01=I01| I02=I02| I03=[[Life treatening]] Nose [[bleeding]] ?}} | {{Familytree | | | | |!| | | | | | I03 | | | |!| | |I01=I01| I02=I02| I03=[[Life treatening]] Nose [[bleeding]] ?}} | ||
{{Familytree | | | | B01 | | | |,|-|^|-|.| | |!| | | B01=Outcome Assement }} | {{Familytree | | | | B01 | | | |,|-|^|-|.| | |!| | | B01=Outcome Assement }} | ||
{{Familytree | | | | |! | {{Familytree | | | | |!| | | | J02 | | J03 | |!| |J01=| J02=Yes→ Evaluate need for or risk of discontinuation [[Anti-Coag]]/[[Anti-Platelet]] medications | J03=No }} | ||
{{Familytree | | | | A01 | | |,|-|^|.| | |!| |!| | | | A01=Discharge }} | {{Familytree | | | | A01 | | |,|-|^|.| | |!| |!| | | | A01=Discharge }} | ||
{{Familytree | | | | | | | | K02 | | K03 |!| |!| | | |K01=K01| K02= [[Bleeding]] controled| K03= [[Bleeding]] resume }} | {{Familytree | | | | | | | | K02 | | K03 |!| |!| | | |K01=K01| K02= [[Bleeding]] controled| K03= [[Bleeding]] resume }} | ||
Line 160: | Line 160: | ||
|- | |- | ||
|} | |} | ||
==Do's== | ==Do's== | ||
* Assess [['''ABC''']] <ref name="TunkelAnne2020">{{cite journal|last1=Tunkel|first1=David E.|last2=Anne|first2=Samantha|last3=Payne|first3=Spencer C.|last4=Ishman|first4=Stacey L.|last5=Rosenfeld|first5=Richard M.|last6=Abramson|first6=Peter J.|last7=Alikhaani|first7=Jacqueline D.|last8=Benoit|first8=Margo McKenna|last9=Bercovitz|first9=Rachel S.|last10=Brown|first10=Michael D.|last11=Chernobilsky|first11=Boris|last12=Feldstein|first12=David A.|last13=Hackell|first13=Jesse M.|last14=Holbrook|first14=Eric H.|last15=Holdsworth|first15=Sarah M.|last16=Lin|first16=Kenneth W.|last17=Lind|first17=Meredith Merz|last18=Poetker|first18=David M.|last19=Riley|first19=Charles A.|last20=Schneider|first20=John S.|last21=Seidman|first21=Michael D.|last22=Vadlamudi|first22=Venu|last23=Valdez|first23=Tulio A.|last24=Nnacheta|first24=Lorraine C.|last25=Monjur|first25=Taskin M.|title=Clinical Practice Guideline: Nosebleed (Epistaxis)|journal=Otolaryngology–Head and Neck Surgery|volume=162|issue=1_suppl|year=2020|pages=S1–S38|issn=0194-5998|doi=10.1177/0194599819890327}}</ref> | * Assess [['''ABC''']] <ref name="TunkelAnne2020">{{cite journal|last1=Tunkel|first1=David E.|last2=Anne|first2=Samantha|last3=Payne|first3=Spencer C.|last4=Ishman|first4=Stacey L.|last5=Rosenfeld|first5=Richard M.|last6=Abramson|first6=Peter J.|last7=Alikhaani|first7=Jacqueline D.|last8=Benoit|first8=Margo McKenna|last9=Bercovitz|first9=Rachel S.|last10=Brown|first10=Michael D.|last11=Chernobilsky|first11=Boris|last12=Feldstein|first12=David A.|last13=Hackell|first13=Jesse M.|last14=Holbrook|first14=Eric H.|last15=Holdsworth|first15=Sarah M.|last16=Lin|first16=Kenneth W.|last17=Lind|first17=Meredith Merz|last18=Poetker|first18=David M.|last19=Riley|first19=Charles A.|last20=Schneider|first20=John S.|last21=Seidman|first21=Michael D.|last22=Vadlamudi|first22=Venu|last23=Valdez|first23=Tulio A.|last24=Nnacheta|first24=Lorraine C.|last25=Monjur|first25=Taskin M.|title=Clinical Practice Guideline: Nosebleed (Epistaxis)|journal=Otolaryngology–Head and Neck Surgery|volume=162|issue=1_suppl|year=2020|pages=S1–S38|issn=0194-5998|doi=10.1177/0194599819890327}}</ref> |
Revision as of 17:30, 16 August 2020
Epistaxis Resident Survival Guide |
---|
Overview |
Causes |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D.
Synonyms and keywords: Epistaxis approach, An approach to epistaxis, Nose bleeding approach
Overview
Epistaxis, also known as, noes bleeding, is a terminology name for bleeding of the nose vessels that drains out from nostril (most often) and/or nasopharynx. Epistaxis often stops easily but sometimes it's an ENT emergency which can be critical if appropriate action does not occur. Kiesselbach's plexus is the source of most epistaxis.
Causes
Base on the cause and severity of Epistaxis it can be life-threatening.[1] [2][3]
Life Threatening Causes
Life-threatening causes of epistaxis include conditions that may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Local trauma
- Acute sinusitis
- Allergic rhinitis
- Anticoagulation
- Aspirin
- Chronic rhinitis
- Chronic sinusitis
- Barotrauma
- Cocaine
- Common cold
- Foreign bodies
- Nose-picking
- Neoplasia
There is not enough evidence that hypertension is a risk factor for epistaxis, and lowering blood pressure to controll and prevention of epistaxis is controversial.
Diagnosis
Shown below is an algorithm summarizing the diagnosis of Epistaxis according to Epistaxis of Emergency Medicine Clinics of North America and Clinical Practice Nosebleed (Epistaxis) Guideline. This guideline was published in the January 2020 issue of the American Academy of Otolaryngology-Head and Neck Surgery.[1] [4] [5] [6] [7]
Patient with Epistaxis? Take a complete medical history | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trauma | Coagulopathy | Vascular abnormalities | Others | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trauma is the most cause of epistaxis(17%) ❑ Digital trauma ❑ Facial trauma ❑ Foreign body insertion ❑ Septal perforation ❑ Barotrauma ❑ Illicit drugs | ❑ Using Anticoagulants or Antiplatelet medications ❑ ITP* ❑ von Willebrand disease ❑ Leukemia ❑ Other medications cause coagulopathy | ❑Sinusitis ❑ Allergies ❑ Septal deviation ❑ Neoplasia in situ ❑ Renal failure ❑ Uremia ❑ Hepatic dysfuction ❑ Idiopathic ❑ Infection | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This algorithm developed and modified according to Epistaxis of Emergency Medicine Clinics of North America and Clinical Practice Nosebleed (Epistaxis) Guideline. This guideline was published in the January 2020 issue of the American Academy of Otolaryngology-Head and Neck Surgery. |
---|
Treatment
Shown below is an algorithm summarizing the treatment of [[Epistaxis]] according to The American Academy of ENT guidelines. [4] [6] [8] [9]
Patient with Epistaxis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
First assess ABC | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Need of Immediate Action? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Active Bleeding ? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes→Nasal compression for≥5 min | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bleeding resume | Bleeding Controlled | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rhinoscopy to identify location of bleeding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bleeding site identified? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rhinoscopy to identify location of bleeding | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bleeding site Identified | Bleeding site not identified | Decision for Nausal Cautery? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anestesia bleeding site and limit Nasal cautery to site | Yes→ Anestesia bleeding site and limit Nasal Cautery to site | No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bleeding controlled | Bleeding resume | Rist factor assessment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Suspected Bleeding site HHT** or on anticoagulants? | Patient education and prevention | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NO→Non absorbable or Absorbable packing(Preferred in children) | Yes→Absorbable packing | Outcome Assesment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nasal packing education | Discharge | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bleeding controlled | Bleeding resume | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Patient use anticoagulant or antiplatelet medications | Patient doesn't use anticoagulant or antiplatelet medications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Patient Education and prevention | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Life treatening Nose bleeding ? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outcome Assement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes→ Evaluate need for or risk of discontinuation Anti-Coag/Anti-Platelet medications | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discharge | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bleeding controled | Bleeding resume | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evaluate candidency for embolization or surgical arterial ligation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Appropriate intervention which may include embolization, Surgery, Additional Nasal packing or Cautery | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Patient Education and Prevention | Outcome Assesment | Discharge | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This algorithm developed and modified according to Epistaxis of Emergency Medicine Clinics of North America and Clinical Practice Nosebleed (Epistaxis) Guideline. This guideline was published in the January 2020 issue of the American Academy of Otolaryngology-Head and Neck Surgery. |
---|
Do's
- Absorbable packs are preferred in children because the removal of the nonabsorbable pack is difficult.
- Before Nasal cautery anesthetize the bleeding area and limit cauterization just to the bleeding site.
- Remove blood clots before rhinoscopy.
- Educate patients and their caregivers about preventive methods for epistaxis.
Don'ts
- Discontinue anticoagulant medications or reverse anticoagulation before cost-benefit assessment.[4]
- Give additional does of anticoagulant in active bleeding.
- After nasal packing don't educate the patient or caregiver about nasal packing sustenance.
References
- ↑ 1.0 1.1 Krulewitz, Neil Alexander; Fix, Megan Leigh (2019). "Epistaxis". Emergency Medicine Clinics of North America. 37 (1): 29–39. doi:10.1016/j.emc.2018.09.005. ISSN 0733-8627.
- ↑ Douglas, Richard; Wormald, Peter-John (2007). "Update on epistaxis". Current Opinion in Otolaryngology & Head and Neck Surgery. 15 (3): 180–183. doi:10.1097/MOO.0b013e32814b06ed. ISSN 1068-9508.
- ↑ Kikidis, D.; Tsioufis, K.; Papanikolaou, V.; Zerva, K.; Hantzakos, A. (2013). "Is epistaxis associated with arterial hypertension? A systematic review of the literature". European Archives of Oto-Rhino-Laryngology. 271 (2): 237–243. doi:10.1007/s00405-013-2450-z. ISSN 0937-4477.
- ↑ 4.0 4.1 4.2 4.3 Tunkel, David E.; Anne, Samantha; Payne, Spencer C.; Ishman, Stacey L.; Rosenfeld, Richard M.; Abramson, Peter J.; Alikhaani, Jacqueline D.; Benoit, Margo McKenna; Bercovitz, Rachel S.; Brown, Michael D.; Chernobilsky, Boris; Feldstein, David A.; Hackell, Jesse M.; Holbrook, Eric H.; Holdsworth, Sarah M.; Lin, Kenneth W.; Lind, Meredith Merz; Poetker, David M.; Riley, Charles A.; Schneider, John S.; Seidman, Michael D.; Vadlamudi, Venu; Valdez, Tulio A.; Nnacheta, Lorraine C.; Monjur, Taskin M. (2020). "Clinical Practice Guideline: Nosebleed (Epistaxis)". Otolaryngology–Head and Neck Surgery. 162 (1_suppl): S1–S38. doi:10.1177/0194599819890327. ISSN 0194-5998.
- ↑ Thornton, M A.; Mahesh, B N.; Lang, J (2005). "Posterior Epistaxis: Identification of Common Bleeding Sites". The Laryngoscope. 115 (4): 588–590. doi:10.1097/01.mlg.0000161365.96685.6c. ISSN 0023-852X.
- ↑ 6.0 6.1 Chaaban, Mohamad R.; Zhang, Dong; Resto, Vicente; Goodwin, James S. (2016). "Demographic, Seasonal, and Geographic Differences in Emergency Department Visits for Epistaxis". Otolaryngology–Head and Neck Surgery. 156 (1): 81–86. doi:10.1177/0194599816667295. ISSN 0194-5998.
- ↑ Viehweg, Tate L.; Roberson, John B.; Hudson, J.W. (2006). "Epistaxis: Diagnosis and Treatment". Journal of Oral and Maxillofacial Surgery. 64 (3): 511–518. doi:10.1016/j.joms.2005.11.031. ISSN 0278-2391.
- ↑ Béquignon, E; Teissier, N; Gauthier, A; Brugel, L; De Kermadec, H; Coste, A; Prulière-Escabasse, V (2017). "Emergency Department care of childhood epistaxis". Emergency Medicine Journal. 34 (8): 543–548. doi:10.1136/emermed-2015-205528. ISSN 1472-0205.
- ↑ Escabasse, V.; Bequignon, E.; Vérillaud, B.; Robard, L.; Michel, J.; Malard, O.; Crampette, L.; Malard, O.; Crampette, L.; Achache, M.; Alaoui Lamrani, M.Y.; Ardillon, L.; Babin, E.; Bal Dit Sollier, C.; Bequignon, E.; Borsik, M.; Castillo, L.; Coste, A.; Debry, C.; Dessi, P.; Drouet, L.; Dufour, X.; Dupuis-Girod, S.; Faure, F.; Gallet, P.; Guldman, R.; Houdart, E.; Jankowski, R.; Jegoux, F.; Leble, S.; Michel, J.; Mortuaire, G.; Mouchon, E.; Page, C.; Pruliere Escabasse, V.; Robard, L.; Roux, A.; Saint Maurice, J.P.; Sarlon, G.; Strunski, V.; Trevillot, V.; Verillaud, B.; Vironneau, P. (2017). "Guidelines of the French Society of Otorhinolaryngology (SFORL). Managing epistaxis under coagulation disorder due to antithrombotic therapy". European Annals of Otorhinolaryngology, Head and Neck Diseases. 134 (3): 195–199. doi:10.1016/j.anorl.2016.10.001. ISSN 1879-7296.